Seventeen patients affected by fibromyalgia syndrome (FMS) (16 females and
one male) and 17 matched healthy subjects underwent formal polysomnography,
a sleep questionnaire and lung function tests.
FMS patients slept significantly less efficiently than the healthy controls
(p<0.01), had a higher proportion of stage 1 sleep (mean+/-SD, 21+/-6% ver
sus 11+/-4%; p<0.001), less slow wave sleep (p<0.01) and twice as many arou
sals per hour of sleep (p<0.001). The respiratory pattern of FMS patients s
howed a high occurrence of periodic breathing (PB) (15+/-8% of total sleep
time) in 15/17 patients, versus 2/17 control subjects. The short length of
apnoeas and hypopnoeas did not affect the apnoea/ hypopnoea index (5.1+/-3.
5 versus 3.2+/-1.6; Ns), but FMS patients had a greater number of desaturat
ions per hour of sleep (8+/-5 versus 3+/-3; p<0.01).
Pulmonary volumes did not differ between the two groups, but FMS patients h
ad a lower transfer factor of the lung for carbon monoxide (TL,CO (5.8+1 ve
rsus 7.7+1 mmol.min(-1).kPa(-1); p=0.001). PB occurrence correlated with TL
,CO (r=-0.62; p=0.01), number of desaturations (r=0.76, p=0.001) and carbon
dioxide tension in arterial blood (Pa,CO2) (r=-0.50; p=0.05). Stepwise mul
tiple linear regression analysis showed desaturation frequency (p=0.0001) a
nd TL,CO (p=0.029) to be the best predictors of PB percentage (R-2 0.73; p=
0.0001).
Patients complaining of daytime hypersomnolence had a higher number of tend
er points, about twice as many arousals per hour and a lower sleep efficien
cy than patients who did not report this symptom. TL,CO was more impaired a
nd the occurrence of PB was higher.
The occurrence of periodic breathing in fibromyalgia syndrome patients, whi
ch was previously unreported, and is shown to be linked to a reduction of t
ransfer factor of the lung for carbon monoxide could play a major role in t
he symptoms of poor sleep of these patients.